PRP8 Activators

The chemical class called PRP8 Activators includes compounds that can indirectly influence the activity of PRP8 through their effects on RNA processing, spliceosome function, and cellular signaling pathways. These compounds do not directly activate PRP8; instead, they create cellular conditions or modulate pathways that could enhance PRP8's functional role in RNA splicing.

Compounds like Pladienolide B, Spliceostatin A, Meayamycin, Sudemycin D6, E7107, and Madrasin target components of the spliceosome complex. By influencing spliceosome function, these compounds could indirectly impact PRP8's activity in RNA splicing. Isoginkgetin, with its inhibitory effect on mRNA splicing, represents another potential indirect modulator of PRP8. Chloroquine and Tetrodotoxin, by affecting cellular processes like autophagy and ion balance, might create an environment that indirectly influences PRP8's activity. Forskolin, through its action on cAMP levels, might impact cellular signaling pathways relevant to RNA processing. Sodium Butyrate and JQ1, as modulators of gene expression and transcription, could also indirectly affect PRP8's function in RNA splicing.